Natera, Inc. (NTRA): Price and Financial Metrics


Natera, Inc. (NTRA): $37.34

-1.71 (-4.38%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NTRA POWR Grades


  • NTRA scores best on the Value dimension, with a Value rank ahead of 52.94% of US stocks.
  • NTRA's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • NTRA ranks lowest in Momentum; there it ranks in the 5th percentile.

NTRA Stock Summary

  • In terms of twelve month growth in earnings before interest and taxes, Natera Inc is reporting a growth rate of 115.69%; that's higher than 82.71% of US stocks.
  • As for revenue growth, note that NTRA's revenue has grown 59.97% over the past 12 months; that beats the revenue growth of 85% of US companies in our set.
  • In terms of volatility of its share price, NTRA is more volatile than 83.18% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Natera Inc are PTE, CDNA, AMWL, VRCA, and ASTC.
  • Visit NTRA's SEC page to see the company's official filings. To visit the company's web site, go to www.natera.com.

NTRA Valuation Summary

  • NTRA's price/sales ratio is 22; this is 93.83% higher than that of the median Healthcare stock.
  • Over the past 75 months, NTRA's price/sales ratio has gone up 15.1.
  • NTRA's EV/EBIT ratio has moved up 1076.2 over the prior 75 months.

Below are key valuation metrics over time for NTRA.

Stock Date P/S P/B P/E EV/EBIT
NTRA 2021-08-31 22.0 37.1 -35.3 -37.9
NTRA 2021-08-30 22.3 37.6 -35.7 -38.3
NTRA 2021-08-27 21.9 37.0 -35.2 -37.8
NTRA 2021-08-26 21.4 36.0 -34.3 -36.8
NTRA 2021-08-25 21.4 36.1 -34.3 -36.9
NTRA 2021-08-24 21.3 36.0 -34.2 -36.8

NTRA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NTRA has a Quality Grade of D, ranking ahead of 16.91% of graded US stocks.
  • NTRA's asset turnover comes in at 0.553 -- ranking 46th of 81 Healthcare stocks.
  • CHE, USPH, and VCYT are the stocks whose asset turnover ratios are most correlated with NTRA.

The table below shows NTRA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.553 0.496 -0.316
2021-03-31 0.510 0.498 -0.272
2020-12-31 0.490 0.479 -0.286
2020-09-30 0.509 0.480 -0.277
2020-06-30 0.609 0.472 -0.279
2020-03-31 0.692 0.462 -0.273

NTRA Price Target

For more insight on analysts targets of NTRA, see our NTRA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $150.11 Average Broker Recommendation 1.35 (Strong Buy)

NTRA Stock Price Chart Interactive Chart >

Price chart for NTRA

NTRA Price/Volume Stats

Current price $37.34 52-week high $129.09
Prev. close $39.05 52-week low $26.10
Day low $36.78 Volume 782,000
Day high $38.26 Avg. volume 2,217,454
50-day MA $37.83 Dividend yield N/A
200-day MA $79.99 Market Cap 3.60B

Natera, Inc. (NTRA) Company Bio


Natera Inc. is a genetic testing company that develops and commercializes non-invasive methods for analyzing DNA. The company was founded in 2003 and is based in San Carlos, California.


NTRA Latest News Stream


Event/Time News Detail
Loading, please wait...

NTRA Latest Social Stream


Loading social stream, please wait...

View Full NTRA Social Stream

Latest NTRA News From Around the Web

Below are the latest news stories about Natera Inc that investors may wish to consider to help them evaluate NTRA as an investment opportunity.

Natera: Q4 Earnings Snapshot

AUSTIN, Texas (AP) _ Natera Inc. (NTRA) on Thursday reported a loss of $140.6 million in its fourth quarter. The Austin, Texas-based company said it had a loss of $1.48 per share. The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share. The genetic testing company posted revenue of $173 million in the period, topping Street forecasts. Five analysts surveyed by Zacks expected $168.2 million. For the year, the company reported that its loss widened to $471.7 million, or $5.21 per share. Revenue was reported as $625.5 million. Natera expects full-year revenue in the range of $770 million to $790 million. _____ This story was generated by Automated Insights (http://automatedinsights.com/...

mySA | February 24, 2022

Natera, Inc. 2021 Q4 - Results - Earnings Call Presentation

No summary available.

Seeking Alpha | February 24, 2022

Natera GAAP EPS of -$1.48 misses by $0.18, revenue of $173M beats by $4.19M

Natera press release (NTRA): Q4 GAAP EPS of -$1.48 misses by $0.18.Revenue of $173M (+53.9% Y/Y) beats by $4.19M.Outlook:Natera anticipates 2022 total revenue of $770 million to…

Seeking Alpha | February 24, 2022

Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of -19.35% and 2.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 24, 2022

Natera Reports Fourth Quarter and Full Year 2021 Financial Results

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial results for the fourth quarter and year ended December 31, 2021 and provided an update on recent business progress and financial outlook.

Yahoo | February 24, 2022

Read More 'NTRA' Stories Here

NTRA Price Returns

1-mo -5.87%
3-mo -42.76%
6-mo -60.55%
1-year -58.74%
3-year 63.56%
5-year 258.01%
YTD -60.02%
2021 -6.16%
2020 195.40%
2019 141.33%
2018 55.28%
2017 -23.23%

Continue Researching NTRA

Here are a few links from around the web to help you further your research on Natera Inc's stock as an investment opportunity:

Natera Inc (NTRA) Stock Price | Nasdaq
Natera Inc (NTRA) Stock Quote, History and News - Yahoo Finance
Natera Inc (NTRA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4803 seconds.